1,709
Views
23
CrossRef citations to date
0
Altmetric
Review

The emerging role of dipeptidyl-peptidase-4 as a therapeutic target in lung disease

, &
Pages 147-153 | Received 10 Dec 2019, Accepted 22 Jan 2020, Published online: 31 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Chavan Sakshi, A. Harikrishnan, Selvakumar Jayaraman, Ahana Roy Choudhury & V. Veena. (2022) Predictive medicinal metabolites from Momordica dioica against comorbidity related proteins of SARS-CoV-2 infections. Journal of Biomolecular Structure and Dynamics 40:11, pages 5175-5188.
Read now
Mark Dp Willcox, Karen Walsh, Jason J Nichols, Philip B Morgan & Lyndon W Jones. (2020) The ocular surface, coronaviruses and COVID‐19. Clinical and Experimental Optometry 103:4, pages 418-424.
Read now

Articles from other publishers (21)

Eman A. Ali, Sara G. Tayel & Mona A. Abbas. (2023) Sitagliptin ameliorates busulfan-induced pulmonary and testicular injury in rats through antioxidant, anti-inflammatory, antifibrotic, and antiapoptotic effects. Scientific Reports 13:1.
Crossref
Laura Maintz, Thomas Welchowski, Nadine Herrmann, Juliette Brauer, Claudia Traidl‐Hoffmann, Regina Havenith, Svenja Müller, Claudio Rhyner, Anita Dreher, Matthias Schmid & Thomas Bieber. (2023) IL‐13, periostin and dipeptidyl‐peptidase‐4 reveal endotype‐phenotype associations in atopic dermatitis. Allergy 78:6, pages 1554-1569.
Crossref
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, A. V. Strygin, Yu. V. Gorbunova, E. V. Volotova, I. E. Makarenko, V. B. Saparova, R. V. Drai & V. I. Petrov. (2023) Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use. Pharmacy & Pharmacology 11:1, pages 19-47.
Crossref
Lanlan Zhang, Faming Jiang, Yingying Xie, Yan Mo, Xin Zhang & Chuntao Liu. (2023) Diabetic endothelial microangiopathy and pulmonary dysfunction. Frontiers in Endocrinology 14.
Crossref
Florensa Rosani Purba, Ika Rahayu & Kris Herawan Timotius. (2023) An in silico ADME/T and molecular docking studies of C-glycosyl flavones derived from Peperomia blanda (Jacq.) Kunth for the management of diabetes. Journal of Phytomoleculs and Pharmacology 2:2, pages 83-94.
Crossref
Panayiota Christodoulou, Theodora-Christina Kyriakou, Panagiotis Boutsikos, Maria Andreou, Yuan Ji, Damo Xu, Panagiotis Papageorgis & Maria-Ioanna Christodoulou. (2022) Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma. Biomedicines 10:12, pages 3037.
Crossref
Na Zhang, Sihui Tang, Jinjin Zhang, Biwei Pei, Tingting Pang & Gengyun Sun. (2022) The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates LPS-induced acute lung injury by maintenance of pulmonary microvascular barrier via activating the Epac1/AKT pathway. Biomedicine & Pharmacotherapy 155, pages 113704.
Crossref
Ping‐Ju Chen, Hsueh‐Ju Lu, Yasser Nassef, Chiao‐Wen Lin, Chun‐Yi Chuang, Chia‐Yi Lee, Yu‐Wei Chiu, Shun‐Fa Yang & Wei‐En Yang. (2022) Association of dipeptidyl peptidase IV polymorphism with clinicopathological characters of oral cancer. Journal of Oral Pathology & Medicine 51:8, pages 730-737.
Crossref
Lin Wang, Xiangping Li, Ying Kong, Furong Wang, Qiuyan Zhang, Chao Lin & Rong Rong. (2022) Pharmacokinetics, tissue distribution and excretion of compound 6c, a novel DPP-4 inhibitor, following intragastric administration in rats by ultra-performance liquid chromatography-tandem mass spectrometry. European Journal of Pharmaceutical Sciences 173, pages 106162.
Crossref
Hui-Jun Liao & Jason T. C. Tzen. (2022) The Potential Role of Cyclopeptides from Pseudostellaria heterophylla, Linum usitatissimum and Drymaria diandra, and Peptides Derived from Heterophyllin B as Dipeptidyl Peptidase IV Inhibitors for the Treatment of Type 2 Diabetes: An In Silico Study. Metabolites 12:5, pages 387.
Crossref
James Ropa, Scott Cooper & Hal E Broxmeyer. (2022) Leukemia Inhibitory Factor Promotes Survival of Hematopoietic Progenitors Ex Vivo and Is Post-Translationally Regulated by DPP4. Stem Cells 40:3, pages 346-357.
Crossref
C. Zorampari, Anupam Prakash, Harmeet S. Rehan & Lalit K. Gupta. (2022) Serum dipeptidyl peptidase-4 and eosinophil cationic protein levels in patients of bronchial asthma. Pulmonary Pharmacology & Therapeutics 72, pages 102109.
Crossref
Peng-Fei Li, Chi-Hsiang Chung, Jhih-Syuan Liu, Chieh-Hua Lu, Sheng-Chiang Su, Feng-Chih Kuo, Li-Ju Ho, Kuan-Chan Chen, Yu-Te Su, Nain-Feng Chu, Chien-Hsing Lee, Chang-Hsun Hsieh, Yi-Jen Hung, Fu-Huang Lin, Wu-Chien Chien & Yao-Jen Liang. (2022) Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients. Therapeutic Advances in Respiratory Disease 16, pages 175346662211353.
Crossref
Ran Abuhasira, Irit Ayalon-Dangur, Neta Zaslavsky, Ronit Koren, Mally Keller, Dror Dicker & Alon Grossman. (2021) A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19. Frontiers in Endocrinology 12.
Crossref
Yukiko Takahashi, Takeshi Kawasaki, Hironori Sato, Yoshinori Hasegawa, Steven M. Dudek, Osamu Ohara, Koichiro Tatsumi & Takuji Suzuki. (2021) Functional Roles for CD26/DPP4 in Mediating Inflammatory Responses of Pulmonary Vascular Endothelial Cells. Cells 10:12, pages 3508.
Crossref
Weiwei Qin, Xiao Zhang, Lingnan Chen, Qiujie Li, Benwang Zhang, Lixin Sun & Wei Han. (2021) Differential urine proteome analysis of a ventilator-induced lung injury rat model by label-free quantitative and parallel reaction monitoring proteomics. Scientific Reports 11:1.
Crossref
Jingli Zhang & Lixia Liu. (2021) Anagliptin alleviates lipopolysaccharide‑induced inflammation, apoptosis and endothelial dysfunction of lung microvascular endothelial cells. Experimental and Therapeutic Medicine 22:6.
Crossref
Lingming Kong, Jie Deng, Xiang Zhou, Binbin Cai, Baofu Zhang, Xiaohu Chen, Zongjing Chen & Weiming Wang. (2021) Sitagliptin activates the p62–Keap1–Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury. Cell Death & Disease 12:10.
Crossref
Yasaman Sharifi, Moloud Payab, Erfan Mohammadi-Vajari, Seyed Morsal Mosallami Aghili, Farshad Sharifi, Neda Mehrdad, Elham Kashani, Zhaleh Shadman, Bagher Larijani & Mahbube Ebrahimpur. (2021) Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review. Journal of Diabetes & Metabolic Disorders 20:2, pages 1743-1765.
Crossref
Hanlin Yin, Rui Li, Liangjing Lu & Qingran Yan. (2020) Understanding Fibrosis in Systemic Sclerosis: Novel and Emerging Treatment Approaches. Current Rheumatology Reports 22:11.
Crossref
Shu-Yi Liao, Megan R. Showalter, Angela L. Linderholm, Lisa Franzi, Celeste Kivler, Yao Li, Michael R. Sa, Zachary A. Kons, Oliver Fiehn, Lihong Qi, Amir A. Zeki & Nicholas J. Kenyon. (2020) l-Arginine supplementation in severe asthma. JCI Insight 5:13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.